![Christopher Pierce](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Christopher Pierce
Eerdere bekende functies van Christopher Pierce
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PRELUDE THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 01-07-2020 | 30-09-2021 |
Scout Advisers LLC | Corporate Officer/Principal | 01-08-2019 | 01-07-2020 |
LOXO ONCOLOGY INC | Corporate Officer/Principal | 01-04-2017 | 01-05-2019 |
PFIZER, INC. | Corporate Officer/Principal | 01-07-2016 | 01-03-2017 |
Opleiding van Christopher Pierce
Harvard Business School | Masters Business Admin |
Harvard College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PFIZER, INC. | Health Technology |
PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Loxo Oncology, Inc.
![]() Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Scout Advisers LLC |
- Beurs
- Insiders
- Christopher Pierce
- Ervaring